Table I
Primers used in this study for the detection of macrolide resistance-related genes.
| Gene | Primer | Sequence (5’→3’) | Purpose | Restriction endonuclease | Vector | Amplicon size (bp) | Annealing temperature |
|---|---|---|---|---|---|---|---|
| mphE | mphE-SF | ATGCCCAGCATATAAATCGC | Screening | 271 | 60°C | ||
| mphE-SR | ATATGGACAAAGATAGCCCG | ||||||
| mphE-OF | CGGAATTCTATTCAAAAAAACTTATCCGACTTA | Cloning | EcoR I | pUCP18 | 885 | 60°C | |
| mphE-OR | CCAAGCTTTTATATAACTCCCAACTGAGCTTTT | Hind III | |||||
| msrE | msrE-SF | TATAGCGACTTTAGCGCCAA | Screening | 395 | 62°C | ||
| msrE-SR | GCCGTAGAATATGAGCTGAT | ||||||
| msrE-OF | CGGAATTCTTTTTGGGAGGACACTGTGATGCTA | Cloning | EcoR I | pUCP18 | 1,467 | 62°C | |
| msrE-OR | CCAAGCTTTTATATAACTCCCAACTGAGCTTTT | Hind III |
Table II
The MIC values for 13 antibiotics against 262 clinical Pseudomonas aeruginosa isolates.
| Antibiotics | MIC range (μg/ml) | MIC50 (μg/ml) | MIC90 (μg/ml) | Resistance (%) |
|---|---|---|---|---|
| Cefuroxim | 0.5–32 | 16 | > 32 | 44.1 |
| Cefepime | 1–64 | 8 | 64 | 36.7 |
| Meropenam | 0.0125–32 | 4 | 32 | 30.1 |
| Ceftazidime | 1–64 | 16 | > 64 | 52.1 |
| Gentamicin | 0.125–64 | 16 | 64 | 32.1 |
| Tobramycin | 0.5–32 | 4 | > 32 | 29.6 |
| Amikacin | >256 | 2 | > 256 | 34.9 |
| Netilmicin | 0.5–512 | 8 | > 512 | 42.1 |
| Colistin | 0.25–16 | 2 | > 16 | 28.2 |
| Azithromycin | 0.5–256 | 64 | > 256 | 78.1 |
| Clarithromycin | 1–1024 | 256 | > 1024 | 69.5 |
| Roxithromycin | 0.5–1024 | 256 | > 1024 | 76.8 |
| Erythromycin | 1–1024 | 512 | > 1024 | 82.1 |
Table III
Coverage and abundance of the macrolide resistance genes in the pooled DNA from 262 Pseudomonas aeruginosa isolates.
Table IV
MIC results for the recombinants, clinical strains, and controls (μg/ml).
| Strain | ERY | KIT | ROX | CLR | AZM |
|---|---|---|---|---|---|
| pUCP18-msrE/DH5α (PAO2276) | 512 | 256 | 1024 | 256 | 32 |
| pUCP18-msrE/DH5α (PAO2883) | 512 | 512 | 1024 | 256 | 32 |
| pUCP18-mphE/DH5α (PAO1609) | 512 | 256 | 1024 | 256 | 32 |
| pUCP18-mphE/DH5α (PAO2883) | 512 | 512 | 1024 | 256 | 32 |
| PAO2883 | 1024 | 512 | 1024 | 512 | > 128 |
| PAO2276 | 512 | 256 | 1024 | 512 | > 128 |
| PAO1609 | > 1024 | 256 | 1024 | 512 | > 128 |
| pUCP18/DH5α | 128 | 256 | 128 | 32 | 4 |
| DH5α | 128 | 512 | 128 | 32 | 4 |
| ATCC 27853 | 32 | 16 | 64 | 16 | < 1 |
Table V
Amino acid polymorphisms in the MsrE variants.
| Accession No. | Amino acid positiona | Reference | ||||||
|---|---|---|---|---|---|---|---|---|
| 45 | 79 | 80 | 128 | 183 | 198 | 444 | ||
| MG585957.1 | Ser | Glu | Thr | Ser | Glu | Glu | Ile | Gonzalez-Plaza et al. 2018 |
| MG585949.1 | Ile | Asp | Gonzalez-Plaza et al. 2018 | |||||
| CP032136.1 | Asp | |||||||
| LS992184.1 | Gly | Asp | ||||||
| CP026233.1 | Asp | Val | Weingarten et al. 2018 | |||||
| CP021960.1 | Lys | Asp | ||||||
| CP011374.1 | Gly | Asp | Lys | |||||
| MsrE-2276 | Asp | this study | ||||||
| MsrE-2883 | Asp | this study | ||||||
Table VI
Amino acid polymorphisms in the MphE variants.
| Accession No. | Amino acid positiona | Reference | |||
|---|---|---|---|---|---|
| 17 | 28 | 133 | 231 | ||
| CP029638.1 | Ile | Ile | Glu | Thr | Beker et al. 2018 |
| CP035931.1 | Leu | ||||
| KX443408.1 | Leu | Asp | |||
| CP011374.1 | Leu | Leu | Ile | ||
| mphE-1609 | Leu | this study | |||
| mphE-2883 | Leu | this study | |||